HUTCHMED (China) (HMDCF) Notes Payables (2016 - 2023)
HUTCHMED (China)'s (HMDCF) quarterly Notes Payables came in at $2.0 million in Q2 2023, down 5.09% year-over-year from $2.1 million in Q2 2022, and down 6.85% quarter-over-quarter from $2.1 million in Q4 2022.
Analysis
HUTCHMED (China) (HMDCF) Notes Payables (2016 - 2023) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Notes Payables for 8 consecutive years, with $2.0 million the latest figure, recorded in Q2 2023.
- On a quarterly basis, Notes Payables fell 5.09% year-over-year to $2.0 million in Q2 2023; TTM through Jun 2023 was $2.0 million, a 5.09% decrease from a year earlier, with the FY2022 full-year figure at $2.1 million, up 9.71% from the prior year.
- Notes Payables was $2.0 million for Q2 2023 at HUTCHMED (China), down from $2.1 million in the prior quarter.
- Over five years, Notes Payables peaked at $2.1 million in Q4 2022 and troughed at $366000.0 in Q4 2019.
- A 5-year average of $1.3 million and a median of $1.9 million in 2021 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables declined 15.28% in 2019 and jumped 381.78% in 2022, its largest moves.
- Over 5 years, Notes Payables stood at $366000.0 in 2019, then rose by 9.56% to $401000.0 in 2020, then soared by 377.56% to $1.9 million in 2021, then rose by 9.71% to $2.1 million in 2022, then retreated by 6.85% to $2.0 million in 2023.
- The last three Notes Payables figures came in at $2.0 million (Q2 2023), $2.1 million (Q4 2022), and $2.1 million (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1.96 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Dec 31, 2021 | 1.92 Mn |
| Jun 30, 2021 | 428,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Dec 31, 2019 | 366,000.00 |
| Dec 31, 2018 | 432,000.00 |
| Jun 30, 2018 | 10.69 Mn |
| Dec 31, 2017 | 29.99 Mn |
| Jun 30, 2017 | 26.86 Mn |
| Jun 30, 2016 | 15.08 Mn |